Marc Belsky's Net Worth
$2.84 Million
Who is Marc Belsky?
Marc Belsky has an estimated net worth of $2.84 Million. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., FIVE PRIME THERAPEUTICS INC, and CELL GENESYS INC.
SEC CIK
Marc Belsky's CIK is 0001382629
Past Insider Trading and Trends
2016 was Marc Belsky's most active year for acquiring shares with 13 total transactions. Marc Belsky's most active month to acquire stocks was the month of March. 2016 was Marc Belsky's most active year for disposing of shares, totalling 15 transactions. Marc Belsky's most active month to dispose stocks was the month of March. 2016 saw Marc Belsky paying a total of $1,343,785.45 for 121,772 shares, this is the most they've acquired in one year. In 2016 Marc Belsky cashed out on 137,584 shares for a total of $3,197,847.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.949
Chief Financial OfficerMarc Belsky owns 17,384 units of Common Stock which is worth $16,497.42. From 2018 to 2023 Marc Belsky acquired a total of 17,384 shares in Kezar Life Sciences, Inc. at a cost of $48,334.62.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
∞
| 15.38K |
$2.60 | $39,998.40 | 15.38K |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| +66.67% | 800 |
$2.76 | $2,207.04 | 2K |
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
| +20.00% | 200 |
$4.42 | $884.00 | 1.2K |
Aug 20
| |||
Form 4
| +100.00% | 500 |
$4.82 | $2,410.00 | 1K |
Aug 9
| |||
Form 4
|
∞
| 500 |
$5.67 | $2,835.18 | 500 |
Jul 25 - Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS INC No price found
Senior Vice President and CFOMarc Belsky owns 63,099 units of Common Stock. From 2013 to 2018 Marc Belsky acquired a total of 188,108 shares in FIVE PRIME THERAPEUTICS INC at a cost of $1,343,785.45, Marc also disposed a total of 91,923 shares of FIVE PRIME THERAPEUTICS INC equalling to $4,204,937.41.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.53% | 3K |
—
|
—
| 16.31K |
Feb 26
| |||
Form 4
| -7.30% | -1.05K |
$18.42 | -$19,304.16 | 13.31K |
Feb 5
| |||
Form 4
| -5.14% | -921.00 |
$34.34 | -$31,627.14 | 16.98K |
Sep 1
| |||
Form 4
| -28.75% | -18.88K |
$44.77 | -$845,302.37 | 46.78K |
Mar 1
| |||
Form 4
|
∞
| 12.66K |
—
|
—
| 12.66K |
Feb 7
| |||
Form 4
| -3.36% | -2.28K |
$48.60 | -$110,856.60 | 65.67K |
Jan 3
| |||
Form 4
| +35.98% | 17.98K |
$44.74 | $804,425.20 | 67.95K |
Sep 1
| |||
Form 4
| +6.18% | 5K |
—
|
—
| 85.93K |
Aug 25
| |||
Form 4
|
—
|
0
|
$29.69 | -$1,385,881.50 | 80.93K |
Scheduled
|
Apr 22
| ||
Form 4
|
—
|
0
|
$26.29 | -$780,749.43 | 80.93K |
Scheduled
|
Apr 6
| ||
Form 4
|
—
|
0
|
$22.29 | -$491,855.96 | 80.93K |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
| +1,320.42% | 75K |
—
|
—
| 80.68K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
∞
| 5.68K |
—
|
—
| 5.68K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELL GENESYS INC No price found
VP Finance & CAOMarc Belsky used to own units in Common Stock but no longer holds any shares there. From 2006 to 2009 Marc Belsky acquired a total of 10,120 shares in CELL GENESYS INC, Marc also disposed a total of 10,120 shares of CELL GENESYS INC equalling to $11,376.72.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.46K |
—
|
—
|
0
|
Oct 14
| |||
Form 4
| -36.21% | -3.66K |
$3.11 | -$11,376.72 | 6.46K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
∞
| 10.12K |
—
|
—
| 10.12K |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||